Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Defects in dendritic spines are common to several forms of cognitive deficits, including mental retardation and Alzheimer disease. Because mutation of p21-activated kinase (PAK) can lead to mental retardation and because PAK-cofilin signaling is critical in dendritic spine morphogenesis and actin dynamics, we hypothesized that the PAK pathway is involved in synaptic and cognitive deficits in Alzheimer disease. Here, we show that PAK and its activity are markedly reduced in Alzheimer disease and that this is accompanied by reduced and redistributed phosphoPAK, prominent cofilin pathology and downstream loss of the spine actin-regulatory protein drebrin, which cofilin removes from actin. We found that beta-amyloid (Abeta) was directly involved in PAK signaling deficits and drebrin loss in Abeta oligomer-treated hippocampal neurons and in the Appswe transgenic mouse model bearing a double mutation leading to higher Abeta production. In addition, pharmacological PAK inhibition in adult mice was sufficient to cause similar cofilin pathology, drebrin loss and memory impairment, consistent with a potential causal role of PAK defects in cognitive deficits in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ oligomers reduce activity of LIMK, which in turns leads to dephosphorylated, active cofilin, depolymerization of actin filaments and the generation of actin rods [66].”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [66]
In the citing paper
“In the hippocampus of individuals with Alzheimer’s disease and in animal models of Alzheimer’s disease, PAK activation is markedly reduced and mislocalized69.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [69]
In the citing paper
“A critical regulator of actin assembly in spines is p21-activated kinase (PAK), a downstream effector molecule of Rac69,70.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [69]
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Dendritic regression and spine loss per remaining neurite have been observed in Alzheimer disease with traditional Golgi stainin”
BackgroundCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1×
“Aβ oligomers cause PAK signaling defects To directly test the hypothesis that Aβ oligomers can cause PAK signaling defects, we incubated cultured primary hippocampal neurons with 100 ng ml −1 of soluble Aβ1–42 aggregates prepared with an Aβ oligomer–generating protoco”
MethodAβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498 · cited 1×
“Passive Aβ antibody treatment increases Tg2576 pPAK To further examine the possible role of Aβ in PAK deficits, we reduced the amount of Aβ with an approach that has been consistently demonstrated to clear Aβ and reverse cognitive deficits in App swe Tg mice—passive immunization with an anti-Aβ antibody recognizing th…”
BackgroundRegulation of actin dynamics through phosphorylation of cofilin by LIM-kinase
Arber, S., Barbayannis, F. A., Hanser, H., Schneider, C., Stanyon, C. A., Bernard, O., & Caroni, P. (1998) · Nature · doi:10.1038/31729 · Cited by 1,425 · cited 1×
“However, the inactivation of cofilin (through phosphorylation by PAK via LIM kinase) causes it to lose its ability to bind to F-actin filament”
BackgroundCofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization
Yang, N., Higuchi, O., Ohashi, K., Nagata, K., Wada, A., Kangawa, K., Nishida, E., & Mizuno, K. (1998) · Nature · doi:10.1038/31735 · Cited by 1,294 · cited 1×
“However, the inactivation of cofilin (through phosphorylation by PAK via LIM kinase) causes it to lose its ability to bind to F-actin filament”
BackgroundOccurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159 · cited 1×
“The accumulation of Aβ or the altered processing of its precursor amyloid precursor protein (APP), encoded by the gene App located on chromosome 21, is associated with Alzheimer disease; and increases in the App gene dosage resulting from complete or segmental trisomy 21 lead to early spine and cognitive deficits and,…”
BackgroundSynaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Dendritic Spine Pathology: Cause or Consequence of Neurological Disorders?
Fiala, J. C., Spacek, J., & Harris, K. M. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00158-3 · Cited by 811 · cited 1×
“Although it is possible that dendritic spine defects are merely secondary to upstream deficits in mental retardatio”
BackgroundCofilin Changes the Twist of F-Actin: Implications for Actin Filament Dynamics and Cellular Function
McGough, A., Pope, B., Chiu, W., & Weeds, A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.771 · Cited by 761 · cited 1×
“In addition, cofilin induces conformational changes in actin that prevent other proteins from binding to acti”
BackgroundDocosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N., Ashe, K. H., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.013 · Cited by 707
Self-citation
Cited by
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
“architecture, cause perturbations in axonal transport and reduced cell surface levels of NMDA receptors (White et al. 1999; Maloney et al. 2005; Snyder et al. 2005; Kelly and Ferreira 2006; Tamagno et al. 2006; Zhao et al. 2006).”
BackgroundDendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821
“, 1988), while Ab likely exerts toxicity at the postsynapse (Selkoe, 2002; Shankar et al., 2008; Zhao et al., 2006).”
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
“These findings are consistent with previous reports that cofilin signaling is perturbed in AD brain tissue and in neurons treated with synthetic A (Maloney et al., 2005; Zhao et al., 2006).”
ResultDendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
“A critical regulator of actin assembly in spines is p21-activated kinase (PAK), a downstream effector molecule of Ra”
BackgroundPropagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
“of Early Alzheimer’s Disease”
BackgroundActin in action: the interplay between the actin cytoskeleton and synaptic efficacy.
Cingolani, L. A., & Goda, Y. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2373 · Cited by 831
Actin in dendritic spines: connecting dynamics to function
Hotulainen, P., & Hoogenraad, C. C. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003008 · Cited by 815
“PAK3 inhibition in mice causes cofilin pathology and memory impairment, consistent with a potential causal role of PAK defects in cognitive deficits in Alzheimer’s disease (Zhao et al., 2006).”
BackgroundGTP‐binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo
Bustelo, X. R., Sauzeau, V., & Berenjeno, I. M. (2007) · BioEssays · doi:10.1002/bies.20558 · Cited by 634
Structural and Molecular Remodeling of Dendritic Spine Substructures during Long-Term Potentiation
Bosch, M., Castro, J., Saneyoshi, T., Matsuno, H., Sur, M., & Hayashi, Y. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.021 · Cited by 637
“During these first minutes, the spine is significantly enriched in G1 and G2 proteins.”
Dendritic Spines: The Locus of Structural and Functional Plasticity
Sala, C., & Segal, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00012.2013 · Cited by 465
Alzheimer's disease: synaptic dysfunction and Aβ
Shankar, G. M., & Walsh, D. M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-48 · Cited by 486
“Other studies have reported that the application of sub-lethal concentrations of various non-fibrillar Aβ assemblies can alter neuronal architecture, cause perturbations in axonal transport and reduced cell surface levels of NMDA receptors [130,131,136-139].”
Shibata, S., Nagase, M., Yoshida, S., Kawarazaki, W., Kurihara, H., Tanaka, H., Miyoshi, J., Takai, Y., & Fujita, T. (2008) · Nature Medicine · doi:10.1038/nm.1879 · Cited by 459
“Notably, CA-Rac1–mediated nuclear translocation of mineralocorticoid receptor–GFP was significantly prevented in the presence of PAK18, an inhibitor of PA”
BackgroundSirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease
Julien, C., Tremblay, C., Émond, V., Lebbadi, M., Salem, N., Bennett, D. A., & Calon, F. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181922348 · Cited by 468
“Because AD is also characterized by a loss of synaptic proteins drebrin, synaptophysin, and PAK (37, 43, 44), we assessed the relationship between SIRT1 and selected synaptic markers.”
BackgroundInfluentialSelf-citationProbing the biology of Alzheimer’s disease in mice
Ashe, K. H., & Zahs, K. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.031 · Cited by 413
Rho family GTPases: Key players in neuronal development, neuronal survival, and neurodegeneration
Stankiewicz, T. R., & Linseman, D. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00314 · Cited by 391
“Rac1 enhanced the activation of rotenone-dependent ROS formation and inhibition of Rac1 utilizing NSC23766 decreased ROS release from microglia (Zhou et al., 2012).”
BackgroundArias‐Romero, L. E., & Chernoff, J. (2008) · Biology of the Cell · doi:10.1042/bc20070109 · Cited by 364
“Nevertheless, PAK18 has proven popular as a means to disrupt Pak activation in cells and, more recently, in vivo (Zhao et al., 2006).”
BackgroundRett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate
Maezawa, I., & Jin, L.-W. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5966-09.2010 · Cited by 347
“Notably, dendritic spine defects and altered dendritic postsynaptic proteins in excitatory neurons are shared key features of neurodevelopmental and neurodegenerative disorders that manifest abnormal synaptic plasticity, such as autism, fragile X syndrome, X-linked mental retardation, Down syndrome, and Alzheimer’s di…”
BackgroundSynaptic changes in Alzheimer’s disease and its models
Pozueta, J., Lefort, R., & Shelanski, M. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.050 · Cited by 307
Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease
Knobloch, M., & Mansuy, I. M. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8018-z · Cited by 296
“The activity of PAK is reduced in Aβ oligomer-treated hippocampal neurons and in Tg2576 mice [85] (see the “Aβ-induced disruption of the”
BackgroundRole of actin cytoskeleton in dendritic spine morphogenesis
Sekino, Y., Kojima, N., & Shirao, T. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.029 · Cited by 294
“Studies using Alzheimer's disease animal model also indicated that drebrin is involved in the pathogenesis of Alzheimer's disease (Calon et al., 2004; Mahadomrongkul et al., 2005; Zhao et al., 2006; Lacor et al., 2007).”
MethodHigh-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model
Julien, C., Tremblay, C., Phivilay, A., Berthiaume, L., Émond, V., Julien, P., & Calon, F. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.022 · Cited by 288
“, optical density ; PAK , p21 - activated kinase .”
InfluentialSelf-citationNeuroinflammation and Synaptic Loss
Rao, J. S., Kellom, M., Kim, H.-W., Rapoport, S. I., & Reese, E. A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0708-2 · Cited by 261
Dendritic spines: Revisiting the physiological role
Chidambaram, S. B., Rathipriya, A. G., Bolla, S. R., Bhat, A., Ray, B., Mahalakshmi, A. M., Manivasagam, T., Thenmozhi, A. J., Essa, M. M., Guillemin, G. J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.005 · Cited by 255
Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486
Dolan, B. M., Duron, S. G., Campbell, D. A., Vollrath, B., Rao, B. S. S., Ko, H.-Y., Lin, G. G., Govindarajan, A., Choi, S.-Y., & Tonegawa, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219383110 · Cited by 260
Lin, Y.-C., & Koleske, A. J. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153204 · Cited by 248
“These changes appear to have functional relevance as parallel changes in PAK, cofilin, and drebrin are observed in AD patient samples (Zhao et al. 2006).”
InfluentialStructure, biochemistry, and biology of PAK kinases
Kumar, R., Sanawar, R., Li, X., & Li, F. (2017) · Gene · doi:10.1016/j.gene.2016.12.014 · Cited by 224
Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease
Louneva, N., Cohen, J. W., Han, L.-Y., Talbot, K., Wilson, R. S., Bennett, D. A., Trojanowski, J. Q., & Arnold, S. E. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080434 · Cited by 210
“6,48–51 Caspase-3 has also been implicated in mechanisms of tau-mediated neurodegeneration in AD.”
BackgroundPetratos, S., Li, Q.-X., George, A. J., Hou, X., Kerr, M. L., Unabia, S. E., Hatzinisiriou, I., Maksel, D., Aguilar, M.-I., & Small, D. H. (2008) · Brain · doi:10.1093/brain/awm260 · Cited by 197
“Keywords: RhoA; Rac1; collapsing responsemediator protein-2; amyloid b peptide; neurite dystrophy of Alzheimer’s disease Abbreviations: APP=amyloid precursor protein; MCI=mild cognitive impairment; PAK=p21-activated kinase; HRP=horse-radish peroxidase; AFM=atomic force microscopy”
BackgroundResultThe role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s Disease
Cole, G. M., & Frautschy, S. A. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.08.009 · Cited by 187
“…in vitro caused a loss of inhibitory phosphorylation of cofilin resulting in its activation and a loss of drebrin's association with actin and reduced drebrin levels; further, in vivo anti-Ab antibody infusion corrected cytosolic PAK and drebrin loss in APPsw transgenic mice (Zhao et al., 2006).”
BackgroundInfluentialSelf-citationHeredia, L., Helguera, P., de Olmos, S., Kedikian, G., Sola Vigo, F., LaFerla, F., Staufenbiel, M., de Olmos, J., Busciglio, J., Caceres, A., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5567-05.2006 · Cited by 182
Actin dynamics and cofilin‐actin rods in alzheimer disease
Bamburg, J. R., & Bernstein, B. W. (2016) · Cytoskeleton · doi:10.1002/cm.21282 · Cited by 181
“Furthermore, intracerebro-ventricular injection of a Pak inhibitory peptide into WT mice induced rod-like cofilin pathology and deficits in social recognition memory [Zhao et al., 2006].”
BackgroundMethodInfluentialHu, S., Begum, A. N., Jones, M. R., Oh, M. S., Beech, W. K., Beech, B. H., Yang, F., Chen, P., Ubeda, O. J., Kim, P. C., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.007 · Cited by 174
Self-citationArc protein: a flexible hub for synaptic plasticity and cognition
Nikolaienko, O., Patil, S., Eriksen, M. S., & Bramham, C. R. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.09.006 · Cited by 183
Cytoskeletal pathologies of Alzheimer disease
Bamburg, J. R., & Bloom, G. S. (2009) · Cell Motility · doi:10.1002/cm.20388 · Cited by 171
“Cofilin pathology in both AD and DS is spatially and temporally associated with marked reduction of PAK protein levels and activity [Zhao et al., 2006].”
InfluentialADF/Cofilin-Actin Rods in Neurodegenerative Diseases
Bamburg, J. R., Bernstein, B. W., Davis, R. C., Flynn, K. C., Goldsbury, C., Jensen, J. R., Maloney, M. T., Marsden, I. T., Minamide, L. S., Pak, C. W., et al. (2010) · Current Alzheimer Research · doi:10.2174/156720510791050902 · Cited by 173
“A seldom examined molecular pathology of AD brains, named cofilin pathology because of the abnormal immunostaining of cofilin [7,8], may help explain the development of sporadic AD and link its pathology to familial AD.”
BackgroundZheng, Y., Xia, Y., Hawke, D., Halle, M., Tremblay, M. L., Gao, X., Zhou, X. Z., Aldape, K., Cobb, M. H., Xie, K., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.013 · Cited by 172
“Cells were treated with PBS, PAK18 (10 mM), or PAK18 control (10 mM) for 48 hr. shRNA specific against Fgd1 or Asef blocked Ras-induced Cdc42 activation (Figure S2C; data of Asef not shown) and abrogated the effect of Ras on FAK dephosphorylation (Figure 2F).”
BackgroundInfluentialZhang, D., Pekkanen-Mattila, M., Shahsavani, M., Falk, A., Teixeira, A. I., & Herland, A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.028 · Cited by 171
“The strongest indication of this is that only in the 3D SAP matrix we get a redistribution of pPAK upon stimulation with Ab oligomers, resembling of what has been observed in other models of AD [20].”
InfluentialPoukkula, M., Kremneva, E., Serlachius, M., & Lappalainen, P. (2011) · Cytoskeleton · doi:10.1002/cm.20530 · Cited by 168
“Drebrin competes for F-actin binding with many other proteins including ADF/cofilins, tropomyosins, a-actinin, and fascin [Ishikawa et al., 1994; Sasaki et al., 1996; Zhao et al., 2006; Grintsevich et al., 2010].”
BackgroundApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease
Lane-Donovan, C., & Herz, J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.12.001 · Cited by 157
“Aβ oligomers reduce activity of LIMK, which in turns leads to dephosphorylated, active cofilin, depolymerization of actin filaments and the generation of actin rods [66].”
BackgroundDendritic spine dynamics--a key role for kalirin-7
Penzes, P., & Jones, K. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.001 · Cited by 157
“Additionally, active PAK prevents Ab oligomer-induced toxicity, whereas inhibition of PAK causes AD-like synaptic pathology [ 71 ].”
Zumkehr, J., Rodríguez‐Ortiz, C. J., Cheng, D., Kieu, Z., Wai, T., Hawkins, C., Kilian, J., Lim, S., Medeiros, R., & Kitazawa, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.005 · Cited by 167
“In addition, a significant restoration of PSD95 immunoreactivity in CA1 hippocampus was also observed in the ceftriaxone-treated 3xTg-AD mice (p < 0.001 and p< 0.05; Fig.”
InfluentialTransmitting on actin: synaptic control of dendritic architecture
Schubert, V., & Dotti, C. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03337 · Cited by 153
PAK signalling in neuronal physiology
Kreis, P., & Barnier, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.11.001 · Cited by 165
Jeong, A., Suazo, K. F., Wood, W. G., Distefano, M. D., & Li, L. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1458070 · Cited by 146
“Both hypo- and hyper-activation of these small GTPases and their downstream effectors have been shown to have detrimental effects on synaptic plasticity and cognitive functions, and have been implicated in learning and neurodegenerative disorders (Brambilla et al. 1997; Zhao et al. 2006; Haditsch et al. 2009).”
BackgroundRelevance of Transgenic Mouse Models to Human Alzheimer Disease
Morrissette, D. A., Parachikova, A., Green, K. N., & LaFerla, F. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800030200 · Cited by 147
DHA May Prevent Age-Related Dementia
Cole, G. M., & Frautschy, S. A. (2010) · Journal of Nutrition · doi:10.3945/jn.109.113910 · Cited by 164
“Of particular interest, AD patients and AD animal models have synaptic and dendritic loss that may begin with a postsynaptic attack by Ab oligomers (39), whereas DHA shows strong synaptic protection from preformed Ab oligomers in vitro (40), consistent with protection of the dendritic spine marker drebrin in APP Tg mi…”
ResultSelf-citationMatrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis
Orr, A. W., Stockton, R., Simmers, M. B., Sanders, J. M., Sarembock, I. J., Blackman, B. R., & Schwartz, M. A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200609008 · Cited by 141
“For example, PAK inhibition in mice with a cell-permeable peptide was recently shown to mimic Alzheimer’s disease (Zhao et al., 2006).”
BackgroundFang, J., Zhang, P., Wang, Q., Chiang, C.-W., Zhou, Y., Hou, Y., Xu, J., Chen, R., Zhang, B., Lewis, S. J., et al. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00951-z · Cited by 140
“P21-activated kinase 1, encoded by the PAK1 gene, has been implicated in AD [52], and recent studies have revealed that inactivation of PAK1 obliterated social recognition without changing amyloid beta (Aβ)/tau pathology, and also exacerbated synaptic impairment and behavioral deficits in mouse models of AD [53, 54].”
BackgroundKommaddi, R. P., Das, D., Karunakaran, S., Nanguneri, S., Bapat, D., Ray, A., Shaw, E., Bennett, D. A., Nair, D., & Ravindranath, V. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2127-17.2017 · Cited by 135
“Although the upstream regulators of ADF/cofilin such as RAC, CDC42, PAK (Zhao et al., 2006), and LIMK have been reported to be diminished in AD brain and mouse models of AD (Barone et al., 2014), the consequence of this dysregulation on ADF/cofilin and the resulting F-actin destabilization (and…”
BackgroundInfluentialUnPAKing the class differences among p21-activated kinases
Eswaran, J., Soundararajan, M., Kumar, R., & Knapp, S. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.06.002 · Cited by 140
p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis
Ma, Q.-L., Yang, F., Calon, F., Ubeda, O. J., Hansen, J. E., Weisbart, R. H., Beech, W., Frautschy, S. A., & Cole, G. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708034200 · Cited by 128
Self-citationKichina, J. V., Goc, A., Al-Husein, B. A., Somanath, P. R., & Kandel, E. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.492779 · Cited by 138
“The fact that the short peptides may be active in vivo [94,140] suggests that this route could be explored for the development of therapeutic interventions.”
BackgroundInfluentialDevelopmental vulnerability of synapses and circuits associated with neuropsychiatric disorders
Penzes, P., Buonanno, A., Passafaro, M., Sala, C., & Sweet, R. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12261 · Cited by 125
“An important downstream target of kalirin signaling, p21activated kinase, shows reduced activation in response to Ab in vitro and in vivo, and contributes to dendritic spine loss (Zhao et al. 2006).”
BackgroundMetabolic links between diabetes and Alzheimer’s disease
Maher, P. A., & Schubert, D. R. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.18 · Cited by 123
Convergent CaMK and RacGEF signals control dendritic structure and function
Penzes, P., Cahill, M. E., Jones, K. A., & Srivastava, D. P. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.07.002 · Cited by 131
Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease
Penzes, P., & VanLeeuwen, J.-E. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.003 · Cited by 114
PAK family kinases: Physiological roles and regulation
Zhao, Z.-S., & Manser, E. (2012) · Cellular Logistics · doi:10.4161/cl.21912 · Cited by 112
Synaptic activity prompts γ-secretase–mediated cleavage of EphA4 and dendritic spine formation
Inoue, E., Deguchi-Tawarada, M., Togawa, A., Matsui, C., Arita, K., Katahira-Tayama, S., Sato, T., Yamauchi, E., Oda, Y., & Takai, Y. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200809151 · Cited by 114
“Recently, PAK, a downstream target of Rac, was reported to be down-regulated in the Alzheimer’s disease brain (Zhao et al., 2006).”
BackgroundA Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease
Chen, Q., Prior, M., Dargusch, R., Roberts, A., Riek, R., Eichmann, C., Chiruta, C., Akaishi, T., Abe, K., Maher, P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027865 · Cited by 115
Are there roles for brain cell senescence in aging and neurodegenerative disorders?
Tan, F. C. C., Hutchison, E. R., Eitan, E., & Mattson, M. P. (2014) · Biogerontology · doi:10.1007/s10522-014-9532-1 · Cited by 116
“Inhibition of PAK3 signaling results in disrupted dendritic morphology both in primary hippocampal neurons and in vivo in APPswe mice (Zhao et al. 2006).”
Shank3 Deficiency Induces NMDA Receptor Hypofunction via an Actin-Dependent Mechanism
Duffney, L. J., Wei, J., Cheng, J., Liu, W., Smith, K. R., Kittler, J. T., & Yan, Z. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1175-13.2013 · Cited by 115
“…we treated cultures with another PAK inhibitor, PAK18, a 18-mer peptide against the proline-rich domain of PAK that disrupts PAK interaction with the guanine nucleotide exchange factor PIX, reduces cellular PAK phosphorylation, and blocks PAK activation (Maruta et al., 2002; Zhao et al., 2006).”
BackgroundCofilin-mediated neurodegeneration in alzheimer’s disease and other amyloidopathies
Maloney, M. T., & Bamburg, J. R. (2007) · Molecular Neurobiology · doi:10.1007/bf02700622 · Cited by 131
Simón, A. M., de Maturana, R. L., Ricobaraza, A., Escribano, L., Schiapparelli, L., Cuadrado-Tejedor, M., Pérez-Mediavilla, A., Avila, J., Del Río, J., & Frechilla, D. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1096 · Cited by 111
“Furthermore, it has been reported that cofilin signaling is perturbed in AD brain tissue and active cofilin bound to actin was found in pathological inclusions associated to AD [30, 56].”
Actin filaments and microtubules in dendritic spines
Shirao, T., & González‐Billault, C. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12313 · Cited by 102
Evidence of Aβ‐ and transgene‐dependent defects in ERK‐CREB signaling in Alzheimer’s models
Ma, Q., Harris‐White, M. E., Ubeda, O. J., Simmons, M., Beech, W., Lim, G. P., Teter, B., Frautschy, S. A., & Cole, G. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04869.x · Cited by 106
“…therapeutic strategies targeting Ab oligomer by highly specific anti-Ab oligomer antibodies or drugs to limit dysregulation of multiple memory-related signaling pathways, including oligomer sensitive NMDAR/ ERK/CREB, Akt/GSK3b/ptau (Ma et al. 2006), and PAK/ LIMK/cofilin/drebrin (Zhao et al. 2006).”
BackgroundSelf-citationRho GTPases as therapeutic targets in Alzheimer’s disease
Aguilar, B. J., Zhu, Y., & Lu, Q. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0320-4 · Cited by 110
“AD patients • ↓ Rac1 early stage AD • ↑ Cdc42 and Rac1 in select neuronal populations • ↓ Rac1 and PAK1 in frontal and occipital lobes • RhoA ↓ in neuropils, ↑ neurons, and colocalized with hyperphosphorylated tau leading to ↓ RhoA activity [41] [3]”
Cole, G. M., & Frautschy, S. A. (2006) · Nutrition and Health · doi:10.1177/026010600601800307 · Cited by 110
“In particular, A~ oligomers appear to dysregulate signaling from rac>PAK kinases that control actin dynamics in dendritic spines of excitatory neurons resulting in major losses in active soluble PAK and drebrin (Zhao et al., 2006).”
Self-citationOh, D., Han, S., Seo, J., Lee, J.-R., Choi, J., Groffen, J., Kim, K., Cho, Y. S., Choi, H.-S., Shin, H., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1711-10.2010 · Cited by 108
“…Tada and Sheng, 2006), and defective Rho signaling is associated with mental retardation, Alzheimer’s disease, and amyotrophic lateral sclerosis (Blanpied and Ehlers, 2004; Newey et al., 2005; van Galen and Ramakers, 2005; Boda et al., 2006; Zhao et al., 2006; Nadif Kasri and Van Aelst, 2008).”
BackgroundKreis, P., Thévenot, E., Rousseau, V., Boda, B., Muller, D., & Barnier, J.-V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703298200 · Cited by 109
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders
Eira, J., Silva, C. S., Sousa, M. M., & Liz, M. A. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.007 · Cited by 122
Rho-linked genes and neurological disorders
Kasri, N. N., & Aelst, L. V. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0385-1 · Cited by 115
“Interestingly, defects in PAK signaling have also been associated with cognitive deficits in Alzheimer disease (AD) [92].”
BackgroundKojima, N., & Shirao, T. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.02.003 · Cited by 119
Banik, A., Brown, R. E., Bamburg, J., Lahiri, D. K., Khurana, D., Friedland, R. P., Chen, W., Ding, Y., Mudher, A., Padjen, A. L., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150136 · Cited by 102
Activation and Regulation of Caspase-6 and Its Role in Neurodegenerative Diseases
Wang, X.-J., Cao, Q., Zhang, Y., & Su, X.-D. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124414 · Cited by 96
“PAK interacts with the cytoplasmic domain of APP (101), and PAK signaling is involved in the pathophysiology of AD (102).”
Hayashi-Takagi, A., Araki, Y., Nakamura, M., Vollrath, B., Duron, S. G., Yan, Z., Kasai, H., Huganir, R. L., Campbell, D. A., & Sawa, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321109111 · Cited by 101
Desale, S. E., Chidambaram, H., & Chinnathambi, S. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00036-1 · Cited by 99
Woo, J. A., Zhao, X., Khan, H., Penn, C., Wang, X., Joly-Amado, A., Weeber, E., Morgan, D., & Kang, D. E. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.5 · Cited by 99
Rift Valley Fever Virus Strain MP-12 Enters Mammalian Host Cells via Caveola-Mediated Endocytosis
Harmon, B., Schudel, B. R., Maar, D., Kozina, C. L., Ikegami, T., Tseng, C.-T. K., & Negrete, O. A. (2012) · Journal of Virology · doi:10.1128/jvi.02242-12 · Cited by 99
PAK2 Haploinsufficiency Results in Synaptic Cytoskeleton Impairment and Autism-Related Behavior
Wang, Y., Zeng, C., Li, J., Zhou, Z., Ju, X., Xia, S., Li, Y., Liu, A., Teng, H., Zhang, K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.061 · Cited by 101
Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion
Nekrasova, T., Jobes, M. L., Ting, J. H., Wagner, G. C., & Minden, A. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.07.006 · Cited by 101
“The expression levels of group A PAKs were also shown to be reduced in Alzheimer's disease, and pharmacological inhibition of group A PAKs in adult mice leads to memory impairment (Zhao et al., 2006).”
BackgroundZameer, A., Kasturirangan, S., Emadi, S., Nimmagadda, S. V., & Sierks, M. R. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.068 · Cited by 103
Cichon, J., Sun, C., Chen, B., Jiang, M., Chen, X. A., Sun, Y., Wang, Y., & Chen, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301911 · Cited by 95
Ray, M., & Zhang, W. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-136 · Cited by 88
“Studies show that PAK3 levels were increased in early AD subjects, but declined in subjects with severe AD [61,62].”
BackgroundRhodiola rosea L. and Alzheimer's Disease: From Farm to Pharmacy
Nabavi, S. F., Braidy, N., Orhan, I. E., Badiee, A., Daglia, M., & Nabavi, S. M. (2016) · Phytotherapy Research · doi:10.1002/ptr.5569 · Cited by 88
“A recent study showed that a dominant-negative form of PAK1 sensitizes, while the wild-type form ameliorated toxicity induced by cytotoxic Aβ oligomers in cultured primary neurons (Zhao et al., 2006).”
BackgroundAmyloid β1–42 oligomer inhibits myelin sheet formation in vitro
Horiuchi, M., Maezawa, I., Itoh, A., Wakayama, K., Jin, L.-W., Itoh, T., & DeCarli, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.007 · Cited by 84
Rao, J. S., Rapoport, S. I., & Kim, H.-W. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.27 · Cited by 86
RetractedPAK in Alzheimer disease, Huntington disease and X-linked mental retardation
Ma, Q.-L., Yang, F., Frautschy, S. A., & Cole, G. M. (2012) · Cellular Logistics · doi:10.4161/cl.21602 · Cited by 85
“In addition, a large 62% loss in drebrin was also observed in these mice.(9) Therefore, pPAK and cofilin pathology and severe drebrin loss are found in both AD and aged AD APPswe mice, suggesting that the dysregulation of PAK/LIMK/ cofilin signaling pathway might play a significant role in the regulation of synaptic d…”
BackgroundSelf-citationP21-activated kinase 4 – Not just one of the PAK
Dart, A., & Wells, C. M. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.03.002 · Cited by 86
Dietary fatty acids and the aging brain: Nutrition Reviews©, Vol. 68, No. s2
Cole, G. M., Ma, Q.-L., & Frautschy, S. A. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00345.x · Cited by 78
“Nevertheless, already by 2005, a US Department of Health and Human Services-funded evidence-based meta-analysis of the literature on n-3 fatty acids and dementia was able to conclude there was sufficient evidence to warrant clinical trials for the treatment and prevention of AD.35 Since that 2005 review,new studies ha…”
InfluentialSelf-citationp21-Activated Kinase Signaling Regulates Oxidant-Dependent NF-κB Activation by Flow
Orr, A. W., Hahn, C., Blackman, B. R., & Schwartz, M. A. (2008) · Circulation Research · doi:10.1161/circresaha.108.182097 · Cited by 88
Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?
Small, D. H. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.006 · Cited by 85
Fowler, S. W., Chiang, A. C. A., Savjani, R. R., Larson, M. E., Sherman, M. A., Schuler, D. R., Cirrito, J. R., Lesne, S. E., & Jankowsky, J. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0572-14.2014 · Cited by 77
“Consistent with past work (Zhao et al., 2006; Ma et al., 2008), we observed a significant decrease of Thr423 phosphorylation of PAK1 in double transgenic mice (F(1,12) 96.”
BackgroundResultInfluentialIsolation and Characterization of Cytoplasmic Cofilin-Actin Rods
Minamide, L. S., Maiti, S., Boyle, J. A., Davis, R. C., Coppinger, J. A., Bao, Y., Huang, T. Y., Yates, J., Bokoch, G. M., & Bamburg, J. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063768 · Cited by 79
Tau impacts on growth-factor-stimulated actin remodeling
Sharma, V. M., Litersky, J. M., Bhaskar, K., & Lee, G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03378 · Cited by 75
Nguyen, T. V., Galvan, V., Huang, W., Banwait, S., Tang, H., Zhang, J., & Bredesen, D. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05031.x · Cited by 75
“In addition, PAK-1 and PAK-3 loss has been suggested to contribute to the dendritic spine defects and cognitive deficits seen in brains of AD subjects and APP Swedish mice (Zhao et al. 2006).”
BackgroundResultInfluentialEph receptors at synapses: Implications in neurodegenerative diseases
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.016 · Cited by 85
Lanke, V., Moolamalla, S. T. R., Roy, D., & Vinod, P. K. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00153 · Cited by 76
“…in vesicle mediated transport; downregulated in AD patients and AD mice models Cao et al., 2010 PAK3 Reduced activity in AD patients and AD mice models Zhao et al., 2006 NDUFAB1 Role in energy metabolism; downregulated in AD Liang et al., 2008 YWHAZ Identified as AD biomarker using proteomic…”
MethodPrion-like seeding and nucleation of intracellular amyloid-β
Olsson, T. T., Klementieva, O., & Gouras, G. K. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.015 · Cited by 72
Signaling effect of amyloid-β42 on the processing of AβPP
Tabaton, M., Zhu, X., Perry, G., Smith, M. A., & Giliberto, L. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.002 · Cited by 66
“…of Aβ assemblies are also able to alter neuronal architecture, cause perturbations in axonal transport and even down-regulate cell surface levels of NMDA receptors (Kelly and Ferreira, 2006, Maloney et al., 2005, Snyder et al., 1994, Tamagno et al., 2006, White et al., 1999, Zhao et al., 2006).”
BackgroundRac regulates the interaction of fascin with protein kinase C in cell migration
Parsons, M., & Adams, J. C. (2008) · Journal of Cell Science · doi:10.1242/jcs.022509 · Cited by 74
Metadata
- Authors
- Zhao, L., Ma, Q.-L., Calon, F., Harris-White, M. E., Yang, F., Lim, G. P., Morihara, T., Ubeda, O. J., Ambegaokar, S., Hansen, J. E., Weisbart, R. H., Teter, B., Frautschy, S. A., & Cole, G. M.
- Affiliations
- VA Sepulveda Ambulatory Care Center (US)
- University of California, Los Angeles (US)
- Centre hospitalier de l'Université Laval (CA)
- The University of Osaka (JP)
- Corresponding author
- Cole, Greg M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-01-15
- Volume
- 9
- Issue
- 2
- Pages
- 234-242
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1985086842
- Cited by
- 317
- References
- 52
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 8 · 2018: 15 · 2017: 22 · 2016: 16 · 2015: 9 · 2014: 20 · 2013: 22 · 2012: 23
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG16570, AG-10415, R01AG016793, P50AG016570, R01AG013741, P50-AG 16570, P50-AG05142, R01AG010685, AG022080, P60AG010415, P50AG005142, AG10685, AG16793, R01 AG13741, R01AG022080)
- National Institute of Neurological Disorders and Stroke (R01NS043946, NS43946)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- p21-activated kinase, Alzheimer's disease, cognitive impairment, dendritic spines, cofilin, drebrin, actin dynamics, amyloid-beta, amyloid-beta oligomers, hippocampal neurons, memory impairment, synaptic dysfunction
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Cognition Disorders, Disease Models, Animal, Female, Humans, Male, Mice, Transgenic, Neuropeptides, Amyloid beta-Peptides, Protein Serine-Threonine Kinases, Dendritic Spines, Actin Depolymerizing Factors, Mice, Rats, p21-Activated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.